These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28296562)

  • 1. Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.
    Grabowski B; Schmidt MA; Rüter C
    Virulence; 2017 Oct; 8(7):1124-1147. PubMed ID: 28296562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
    Viboud GI; Bliska JB
    Annu Rev Microbiol; 2005; 59():69-89. PubMed ID: 15847602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current activities of the Yersinia effector protein YopM.
    Höfling S; Grabowski B; Norkowski S; Schmidt MA; Rüter C
    Int J Med Microbiol; 2015 May; 305(3):424-32. PubMed ID: 25865799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.
    Cornelis GR; Wolf-Watz H
    Mol Microbiol; 1997 Mar; 23(5):861-7. PubMed ID: 9076724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.
    Cornelis GR
    Folia Microbiol (Praha); 1998; 43(3):253-61. PubMed ID: 9717252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica.
    Trülzsch K; Roggenkamp A; Aepfelbacher M; Wilharm G; Ruckdeschel K; Heesemann J
    Int J Med Microbiol; 2003 Jun; 293(2-3):167-77. PubMed ID: 12868653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological response of sheep to plasmid-encoded proteins of Yersinia species following natural infection with Y. enterocolitica and Y. pseudotuberculosis.
    Robins-Browne RM; Bordun AM; Slee KJ
    J Med Microbiol; 1993 Oct; 39(4):268-72. PubMed ID: 8411087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM.
    Scharnert J; Greune L; Zeuschner D; Lubos ML; Alexander Schmidt M; Rüter C
    Cell Mol Life Sci; 2013 Dec; 70(24):4809-23. PubMed ID: 23835836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Rho GTPases and the actin cytoskeleton by Yersinia outer proteins (Yops).
    Aepfelbacher M; Heesemann J
    Int J Med Microbiol; 2001 Sep; 291(4):269-76. PubMed ID: 11680787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of Yersinia pathogenesis.
    Iriarte M; Cornelis GR
    Microbiologia; 1996 Jun; 12(2):267-80. PubMed ID: 8767710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yersinia as oral live carrier vaccine: influence of Yersinia outer proteins (Yops) on the T-cell response.
    Trülzsch K; Sporleder T; Leibiger R; Rüssmann H; Heesemann J
    Int J Med Microbiol; 2008 Jan; 298(1-2):59-67. PubMed ID: 17897880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Cells Translocated with Yersinia Yops in Infected Tissues Using β-Lactamase Fusions.
    Nguyen GT; McCabe AL; Fasciano AC; Mecsas J
    Methods Mol Biol; 2019; 2010():117-139. PubMed ID: 31177435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling neutrophil-
    Mecsas J
    F1000Res; 2019; 8():. PubMed ID: 31327994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
    Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia effectors target mammalian signalling pathways.
    Juris SJ; Shao F; Dixon JE
    Cell Microbiol; 2002 Apr; 4(4):201-11. PubMed ID: 11952637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the Yersinia YopM protein.
    Boland A; Havaux S; Cornelis GR
    Microb Pathog; 1998 Dec; 25(6):343-8. PubMed ID: 9895273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation.
    Rüssmann H; Weissmüller A; Geginat G; Igwe EI; Roggenkamp A; Bubert A; Goebel W; Hof H; Heesemann J
    Eur J Immunol; 2000 May; 30(5):1375-84. PubMed ID: 10820384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis.
    Chatzipanagiotou S; Legakis JN; Boufidou F; Petroyianni V; Nicolaou C
    Clin Microbiol Infect; 2001 Mar; 7(3):138-43. PubMed ID: 11318812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
    Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
    Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.